Logo

Indications - Bilastine is indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.

Dosage & Administration - • Adults and adolescents (12 years of age and over): 20 mg (1 tablet) once daily. • Children under 12 years: The safety and efficacy in children under 12 years have not been established yet. • Elderly: No dosage adjustments are required for elderly patients. The maximum recommended daily dose of Bilastine is 20 mg which should be taken one hour before or two hours after intake of food.

Side Effects - The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.

Contraindications - Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.

Others - Pregnancy & Lactation There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.